Literature DB >> 1002748

The strength of the anterior cruciate ligament in humans and Rhesus monkeys.

F R Noyes, E S Grood.   

Abstract

The mechanical properties of anterior cruciate bone-ligament-bone specimens from humans and rhesus monkeys were determined in tension to failure under high strain-rate conditions. The age range of the human specimens was from sixteen to eighty-six years. The values fro human specimens obtained from young adults with regard to elastic modulus, ultimate tensile stress, and strain energy to failure were approximately two to three times those for specimens from humans in the sixth decade and older. The major mode of failure was ligament disruption in the specimens from young adult humans and avulsion of bone beneath the ligament insertion site in the specimens from older humans. The difference in mode of failure correlated with histological observations of decreased bone mass at the site of ligament attachment in the specimens from older humans. Rhesus monkey specimens had higher values for elastic modulus, failure stress, and strain energy. Significant reductions in strength and stiffness properties of ligament units were shown to occur with advancing age to a greater degree than expected. All experiments in which specimens from older human cadavera are used should be interpreted with caution when the results are applied to mechanisms of ligament failure for younger or athletic individuals.

Entities:  

Mesh:

Year:  1976        PMID: 1002748

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  119 in total

1.  Collagen fibril diameter distributions in rabbit anterior cruciate and medial collateral ligaments: changes with maturation.

Authors:  R A Hart; W H Akeson; K Spratt; D Amiel
Journal:  Iowa Orthop J       Date:  1999

Review 2.  Biomechanics of the PCL and related structures: posterolateral, posteromedial and meniscofemoral ligaments.

Authors:  A A Amis; A M J Bull; C M Gupte; I Hijazi; A Race; J R Robinson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-09-05       Impact factor: 4.342

3.  Anterior cruciate ligament allograft transplantation for intraarticular ligamentous reconstruction.

Authors:  M Goertzen; A Dellmann; J Gruber; H Clahsen; K F Bürrig
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

4.  Neuromuscular Changes in Female Collegiate Athletes Resulting From a Plyometric Jump-Training Program.

Authors:  Gary B. Wilkerson; Marisa A. Colston; Nancy I. Short; Kristina L. Neal; Paul E. Hoewischer; Jennifer J. Pixley
Journal:  J Athl Train       Date:  2004-03       Impact factor: 2.860

5.  The human anterior cruciate ligament: histological and ultrastructural observations.

Authors:  R Strocchi; V de Pasquale; P Gubellini; A Facchini; M Marcacci; R Buda; S Zaffagnini; A Ruggeri
Journal:  J Anat       Date:  1992-06       Impact factor: 2.610

6.  Biocompatibility and ingrowth of Trevira prostheses following replacement of the cruciate ligaments.

Authors:  H J Kock; K M Stürmer
Journal:  Med Biol Eng Comput       Date:  1992-07       Impact factor: 2.602

7.  Variations in the amount of calcified tissue at the attachments of the quadriceps tendon and patellar ligament in man.

Authors:  E J Evans; M Benjamin; D J Pemberton
Journal:  J Anat       Date:  1991-02       Impact factor: 2.610

8.  [Biomechanical principles of after-care in replacement of the anterior cruciate ligament].

Authors:  S Rupp; T Hopf; M Gleitz; T Hess
Journal:  Unfallchirurgie       Date:  1994-12

9.  Regional mechanical properties of human patellar tendon allografts.

Authors:  Adam Yanke; Rebecca Bell; Andrew Lee; Elizabeth F Shewman; Vincent Wang; Bernard R Bach
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-12       Impact factor: 4.342

10.  The interface between bone and tendon at an insertion site: a study of the quadriceps tendon insertion.

Authors:  J Clark; D J Stechschulte
Journal:  J Anat       Date:  1998-05       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.